October 2012
Intermediate to advanced
524 pages
17h 16m
English
book
Chemical Biology: Approaches to Drug Discovery and Development to Targeting Disease
by Natanya Civjan
Content preview from Chemical Biology: Approaches to Drug Discovery and Development to Targeting Disease
Become an O’Reilly member and get unlimited access to this title plus top books and audiobooks from O’Reilly and nearly 200 top publishers, thousands of courses curated by job role, 150+ live events each month,
O’Reilly covers everything we've got, with content to help us build a world-class technology community, upgrade the capabilities and competencies of our teams, and improve overall team performance as well as their engagement.I wanted to learn C and C++, but it didn't click for me until I picked up an O'Reilly book. When I went on the O’Reilly platform, I was astonished to find all the books there, plus live events and sandboxes so you could play around with the technology.I’ve been on the O’Reilly platform for more than eight years. I use a couple of learning platforms, but I'm on O'Reilly more than anybody else. When you're there, you start learning. I'm never disappointed.I'm always learning. So when I got on to O'Reilly, I was like a kid in a candy store. There are playlists. There are answers. There's on-demand training. It's worth its weight in gold, in terms of what it allows me to do.
Contributors
Cynthia M. Arbeeny, Endocrine and Metabolic Diseases, Genzyme Corporation, Framingham, Massachusetts
Glen B. Baker, Neurochemical Research Unit, Department of Psychiatry, University of Alberta, Edmonton, Alberta, Canada
Peter J. Barnes, National Heart and Lung Institute, Imperial College, London, United Kingdom
Francis Berenbaum, Paris Universitas APHP Saint-Antoine Hospital, Paris, France
Grant E. Boldt, University of Oxford, Oxford, United Kingdom and The Scripps Research Institute, La Jolla, California
Thomas M. Bridges, Department of Pharmacology, Vanderbilt Institute of Chemical Biology, Vanderbilt University Medical Center, Nashville, Tennessee
Doug A. Brooks, Molecular Medicine Sector, Sansom Institute, University of South Australia, Adelaide, Australia
Jianwei Che, Genomics Institute of the Novartis Research Foundation, San Diego, California
Li Di, Wyeth Research, Princeton, New Jersey
Yael Elbaz, Department of Biologic Chemistry, Alexander Silberman Institute of Life Sciences, Hebrew University of Jerusalem, Jerusalem, Israel
Maria Fuller, Lysosomal Diseases Research Unit, Department of Genetic Medicine, Women's and Children's Hospital, Adelaide, Australia
Marjolaine Gosset, Paris Universitas, Paris, France
Nathanael S. Gray, Harvard Medical School, Dana Farber Cancer Institute, Biological Chemistry and Molecular Pharmacology, Boston
Brian T. Hawkins, Laboratory of Pharmacology, NIH/NIEHS, Research Triangle Park, North Carolina
Claire Jacques, Paris Universitas, ...
Become an O’Reilly member and get unlimited access to this title plus top books and audiobooks from O’Reilly and nearly 200 top publishers, thousands of courses curated by job role, 150+ live events each month,
and much more.
Read now
Unlock full access
More than 5,000 organizations count on O’Reilly
O’Reilly covers everything we've got, with content to help us build a world-class technology community, upgrade the capabilities and competencies of our teams, and improve overall team performance as well as their engagement.Julian F.
I wanted to learn C and C++, but it didn't click for me until I picked up an O'Reilly book. When I went on the O’Reilly platform, I was astonished to find all the books there, plus live events and sandboxes so you could play around with the technology.Addison B.
I’ve been on the O’Reilly platform for more than eight years. I use a couple of learning platforms, but I'm on O'Reilly more than anybody else. When you're there, you start learning. I'm never disappointed.Amir M.
I'm always learning. So when I got on to O'Reilly, I was like a kid in a candy store. There are playlists. There are answers. There's on-demand training. It's worth its weight in gold, in terms of what it allows me to do.